ArticleTherapeutic innovation & regulatory science2026

A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System Events for Tazemetostat.

Qiong Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.